Position in REGN
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$743,883
-$177,876 QoQ
Shares Held
1,193
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#715
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Boston Trust Walden Corp holds $230,816,361 across 5 Biotechnology names. REGN ranks #4 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
443,123 | $106,779,348 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,083,062 | $84,771,262 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
440,264 | $38,280,954 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
1,193 | $743,883 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
485 | $240,914 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $743,883 | 1,193 | Shares | Defined | 2026-07-24 | |
| 2026-03-31 | $921,759 | 1,193 | Shares | Defined | 2026-04-24 | |
| 2025-12-31 | $1,121,527 | 1,453 | Shares | Defined | 2026-01-28 | |
| 2025-09-30 | $816,978 | 1,453 | Shares | Defined | 2025-10-17 | |
| 2025-06-30 | $762,825 | 1,453 | Shares | Defined | 2025-07-28 | |
| 2025-03-31 | $921,536 | 1,453 | Shares | Defined | 2025-04-21 | |
| 2024-12-31 | $1,035,015 | 1,453 | Shares | Defined | 2025-01-24 | |
| 2024-09-30 | $1,527,451 | 1,453 | Shares | Defined | 2024-10-24 | |
| 2024-06-30 | $1,548,167 | 1,473 | Shares | Defined | 2024-07-19 | |
| 2024-03-31 | $1,417,747 | 1,473 | Shares | Defined | 2024-04-22 | |
| 2023-12-31 | $1,293,721 | 1,473 | Shares | Defined | 2024-01-24 | |
| 2023-09-30 | $1,212,220 | 1,473 | Shares | Defined | 2023-10-18 | |
| 2023-06-30 | $1,058,409 | 1,473 | Shares | Defined | 2023-07-24 | |
| 2023-03-31 | $1,210,319 | 1,473 | Shares | Defined | 2023-04-19 | |
| 2022-12-31 | $943,708 | 1,308 | Shares | Defined | 2023-01-20 | |
| 2022-09-30 | $901,041 | 1,308 | Shares | Defined | 2022-10-19 | |
| 2022-06-30 | $773,198 | 1,308 | Shares | Defined | 2022-07-22 | |
| 2022-03-31 | $913,533 | 1,308 | Shares | Defined | 2022-04-20 | |
| 2021-12-31 | $826,028 | 1,308 | Shares | Defined | 2022-01-21 | |
| 2021-09-30 | $791,575 | 1,308 | Shares | Defined | 2021-10-25 | |
| 2021-06-30 | $726,102 | 1,300 | Shares | Defined | 2021-07-22 | |
| 2021-03-31 | $615,082 | 1,300 | Shares | Defined | 2021-04-21 | |
| 2020-12-31 | $628,043 | 1,300 | Shares | Defined | 2021-01-15 | |
| 2020-09-30 | $727,714 | 1,300 | Shares | Defined | 2020-10-14 | |
| 2020-06-30 | $818,228 | 1,312 | Shares | Defined | 2020-07-23 | |
| 2020-03-31 | $640,636 | 1,312 | Shares | Defined | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||